Adverse events12

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 12 of 12

Type	Event	Organ system	Group	Affected	At risk
other	scalp itching	Skin and subcutaneous tissue disorders	Treatment Group	1	12
other	scalp itching	Skin and subcutaneous tissue disorders	Control Group	4	12
other	scalp dryness	Skin and subcutaneous tissue disorders	Treatment Group	0	12
other	scalp dryness	Skin and subcutaneous tissue disorders	Control Group	2	12
other	headache	Nervous system disorders	Treatment Group	0	12
other	headache	Nervous system disorders	Control Group	2	12
serious	Blurred vision	Eye disorders	Treatment Group	0	12
serious	Blurred vision	Eye disorders	Control Group	0	12
serious	Chest pain	Musculoskeletal and connective tissue disorders	Treatment Group	0	12
serious	Chest pain	Musculoskeletal and connective tissue disorders	Control Group	0	12
serious	Dizziness	Nervous system disorders	Treatment Group	0	12
serious	Dizziness	Nervous system disorders	Control Group	0	12

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03753113/events